Xenia Hotels & Resorts (XHR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Q3 2024 net loss was $7.1 million ($0.07 per share), a 16.3% year-over-year improvement; year-to-date net income was $16.8 million ($0.16 per share), up 46.1% from 2023.
Adjusted EBITDAre for Q3 2024 was $44.3 million, down 4.4% year-over-year; Adjusted FFO per share was $0.25, down 3.8%.
Portfolio RevPAR increased 1.5%–1.6% year-over-year to $161.20, with occupancy up 320 bps to 67% and ADR down 3.3% to $240.72.
Major renovation and upbranding of Grand Hyatt Scottsdale Resort completed and relaunched in November 2024.
Sold Lorien Hotel & Spa for $30 million, realizing a $1.6 million gain and a 21.3x EBITDA multiple.
Financial highlights
Q3 2024 total revenues were $236.8 million, up 2.1% year-over-year; year-to-date revenues were $777.2 million, up 0.7%.
Q3 same-property hotel EBITDA was $48.1 million, down 6.3% year-over-year; margin decreased 200 bps to 20.3%.
Year-to-date same-property hotel EBITDA was $192.5 million, down 7.0%; margin decreased 210 bps to 24.9%.
Q3 Adjusted FFO was $26.1 million; year-to-date Adjusted FFO was $125.3 million.
Food and beverage revenue grew nearly 5%, but margin declined 15 bps due to higher costs.
Outlook and guidance
Full-year 2024 Adjusted EBITDAre guidance: $234–$242 million; Adjusted FFO: $160–$168 million; net income: $9–$17 million.
Same-property RevPAR growth expected at 1.25%–2.25%; excluding Scottsdale, 2.75%–3.75%.
Capital expenditures projected at $130–$140 million, with $70–$75 million allocated to Grand Hyatt Scottsdale Resort.
Group revenue pace for November–December up over 10%; transient revenue pace up over 6%.
Group revenue pace for 2025 up nearly 20%; excluding Scottsdale, up mid-teens percent.
Latest events from Xenia Hotels & Resorts
- Double-digit earnings growth in 2025 with strong demand; 2026 outlook remains positive.XHR
Q4 202514 Mar 2026 - Net income up, EBITDAre down, and guidance trimmed as renovations and expense pressures persist.XHR
Q2 20242 Feb 2026 - 2025 guidance projects 3.5–6.5% RevPAR growth and $244–$264M Adjusted EBITDAre.XHR
Q4 202423 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and strong governance.XHR
Proxy Filing2 Dec 2025 - Board recommends approval of all proposals, including director elections and plan amendment.XHR
Proxy Filing2 Dec 2025 - Board seeks approval to expand equity awards, reinforcing pay-for-performance alignment.XHR
Proxy Filing2 Dec 2025 - Q1 2025 net income and RevPAR surged, but guidance was trimmed amid macro uncertainty.XHR
Q1 202528 Nov 2025 - Q2 net income soared over 259% on asset sale and group demand, with raised full-year guidance.XHR
Q2 202516 Nov 2025 - Year-to-date net income and EBITDAre rose despite a Q3 net loss and flat RevPAR.XHR
Q3 20252 Nov 2025